Ensuring Adventitious Agent Safety in Biologics

Creating effective strategies to mitigate risk and enable prompt remediation of viral, prion and mycoplasma contamination

17 19 October 2011

Currently in read only mode, sorry about that, please try again in a few hours.

14 speakers

  • Jens-Peter Gregersen @novartis SME Virology, Virus Safety, New Projects R&D, Novartis Vaccines and Diagnostics
  • Thomas R. Kreil, PhD @baxter_intl Associate Professor of Virology Senior Director Viral Vaccines & Global Pathogen Safety Baxter BioScience
  • Emiliano Toso @MerckSerono_de Molecular Biology Lab Head, Merck Serono
  • Sebastien Carayol @sanofipasteur Manager of Scientific Bioprocess R&D, Downstream Process, Sanofi Pasteur
  • Marc Martin Viral Safety Assessor, AFSS APS
  • Walter De Matteo Microbiological Laboratory Manager, Quality Control, IBSA Institut Biochimique SA
  • Hans Nitschko Doctor of Diagnostic Virology, Max von Pettenkofer Institute, University of Munich
  • Barbara Potts Senior Consultant, Potts and Nelson Consulting, LL C, Chair, Mycoplasma Task Force, PDA
  • Tanja Opriessnig Associate Professor, Department of Veterinary Diagnostic and Production Animal Medicine, Veterinary Diagnostic Laboratory - Iowa

14 known attendees

  • Pharmaceutical News
  • Veronica Araujo
  • Rachel Yaroschuk
  • CSL Behring
  • Roche
  • Genzyme Corporation
  • kaitlen
  • AdventAgentSafety
  • Jana Köller
  • Eli Lilly & Company
  • Novartis
  • Baxter International
  • Merck Serono DE
  • Sanofi Pasteur

Tell your friends!

Share this event with your friends on Twitter




1 slide deck

Added 6 years ago

1 audio clip

Added 6 years ago

2 write-ups

Most recent added 6 years ago

2 handouts

Most recent added 6 years ago

See all coverage

6 items in total


Call for participation

Related books

  • Wonders of Life
  • Big Blue Ocean

See something wrong?

Report an issue with this event